TSS
KZR

Two Sigma Securities’s Kezar Life Sciences KZR Stock Holding History

Two Sigma Securities’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,121
Closed -$6.73K – 3284
2024
Q2 		$6.73K Buy
+1,121
New +$8.52K ﹤0.01% 2849
2023
Q2 		– Sell
-1,435
Closed -$44.9K – 3095
2023
Q1 		$44.9K Buy
+1,435
New +$83K ﹤0.01% 2287

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Securities's KZR Position: Q3 2024 in Review

Two Sigma Securities sold out of Kezar Life Sciences (KZR) in Q3 2024, closing a stake of 1,121 shares — an estimated $6.73K sold.

Two Sigma Securities first reported a position in KZR in Q1 2023 and held it in 2 quarters. The position peaked at $44.9K in Q1 2023. 59 funds tracked by Wall St. Rank hold KZR as of Q3 2024.

  • Two Sigma Securities reported no remaining Kezar Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 1,121 Kezar Life Sciences shares in Q3 2024, an estimated $6.73K.
  • Two Sigma Securities first reported a position in Kezar Life Sciences in Q1 2023 and held it in 2 quarters.
  • Two Sigma Securities's Kezar Life Sciences position peaked at $44.9K in Q1 2023.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.